Related Experiment Video
Updated: Sep 14, 2025

06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
Capmatinib treatment in a patient with osimertinib-resistant NSCLC harboring two distinct MET alterations revealed by
Wirote Lausoontornsiri1, Chek Kun Tan2, Dimple Rajgor2
1Department of Medical Oncology, Samitivej Sukhumvit Hospital, Bangkok 10110, Thailand.
Cancer Pathogenesis and Therapy
|July 23, 2025
Abstract
No abstract available in PubMed .

